Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA
- PMID: 24684440
- PMCID: PMC4004227
- DOI: 10.1021/bi401673b
Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA
Abstract
Inflammation and subsequent cyclooxygenase-2 (COX-2) activity has long been linked with the development of cancer, although little is known about any epigenetic effects of COX-2. A product of COX-2 activation, levuglandin (LG) quickly forms covalent bonds with nearby primary amines, such as those in lysine, which leads to LG-protein adducts. Here, we demonstrate that COX-2 activity causes LG-histone adducts in cultured cells and liver tissue, detectable through LC-MS, with the highest incidence in histone H4. Adduction is blocked by a γ-ketoaldehyde scavenger, which has no effect on COX-2 activity as measured by PGE2 production. Formation of the LG-histone adduct is associated with an increased histone solubility in NaCl, indicating destabilization of the nucleosome structure; this is also reversed with scavenger treatment. These data demonstrate that COX-2 activity can cause histone adduction and loosening of the nucleosome complex, which could lead to altered transcription and contribute to carcinogenesis.
Figures





References
-
- Agrawal A.; Fentiman I. S. (2008) NSAIDs and breast cancer: a possible prevention and treatment strategy. Int. J. Clin. Pract. 62, 444–449. - PubMed
-
- Konturek P. C.; Kania J.; Burnat G.; Hahn E. G.; Konturek S. J. (2005) Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. J. Physiol. Pharmacol. 56(Suppl 5), 57–73. - PubMed
-
- Harris R. E. (2009) Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 17, 55–67. - PubMed
-
- Lim B. J.; Jung S. S.; Choi S. Y.; Lee C. S. (2010) Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance. Mol. Med. Rep. 3, 43–49. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials